Satellos Bioscience
MSLE
26 hedge funds and large institutions have $59.6M invested in Satellos Bioscience in 2026 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 7 closing their positions.
30% more capital invested
Capital invested by funds: $45.9M → $59.6M (+$13.7M)
1.82% less ownership
Funds ownership: 38.71% → 36.89% (-1.8%)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
16% less funds holding
Funds holding: 31 → 26 (-5)
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$2.69M |
| 2 |
AIC
AWM Investment Company
New York
|
+$1.24M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$1.12M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$173K |
| 5 |
CUAMC
China Universal Asset Management Company
Shanghai,
China
|
+$93.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$2.66M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.58M |
| 3 |
Millennium Management
New York
|
-$1M |
| 4 |
EAM
Empery Asset Management
New York
|
-$845K |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$687K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CIAM
26
Caitong International Asset Management
Hong Kong
| $8 | – | – | – |
|
|
HF
27
HRT Financial
New York
| – | -$171K | -30,461 | Closed |
|
28
Jane Street
New York
| – | -$110K | -19,608 | Closed |
|
|
MIM
29
Monashee Investment Management
Boston,
Massachusetts
| – | -$67.6K | -12,000 | Closed |
|
|
PBM
30
Propel Bio Management
Los Angeles,
California
| – | -$57.1K | -10,145 | Closed |
|
|
AC
31
AXQ Capital
Jersey City,
New Jersey
| – | -$56.8K | -10,096 | Closed |
|
32
National Bank of Canada
Montreal,
Quebec, Canada
| – | -$11.8K | -2,115 | Closed |
|
|
MCM
33
MAI Capital Management
Independence,
Ohio
| – | -$789 | -140 | Closed |
|
MSLE Hedge Fund Activity: Q2 2026 in Review
26 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in Satellos Bioscience (MSLE) for Q2 2026, worth a combined $59.6M — up 30% from $45.9M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of MSLE and 2 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 6 added.
The largest buyer was Stonepine Capital Management, adding an estimated $2.69M. The largest seller was Avidity Partners Management, cutting an estimated $2.66M.
- 26 institutional investors held Satellos Bioscience (MSLE) as of Q2 2026, down from 31 in Q1 2026.
- Funds reported $59.6M of Satellos Bioscience stock for Q2 2026, up 30% quarter-over-quarter.
- 2 funds opened new Satellos Bioscience positions in Q2 2026 and 7 closed out, a net change of -5 holders.
- The largest Satellos Bioscience buyer in Q2 2026 was Stonepine Capital Management, an estimated $2.69M added.
- The largest Satellos Bioscience seller in Q2 2026 was Avidity Partners Management, an estimated $2.66M sold.
Based on aggregated 13F filings for Q2 2026.